tci Part B Insider - 2003 Issue 10

LOCAL COVERAGE POLICIES: CIGNA Policies Limit Sinus Endoscopy

In Tennessee, Cigna Healthcare unveiled two new draft local medical review policies with comments due by Aug. 12: * Alefacept therapy (J3490). This treatment for psoriasis is covered only for chronic plaque psoriasis. Patients must have failed to respond to topical and UVB therapies, have a medical contraindication to such therapies, or give rise to a reasonable expectation that such therapies wouldn't be effective. The patient may repeat this therapy if the initial course results in remission and then 12 weeks elapses before a relapse.Physicians must have CD4+ lymphocyte counts available, and they must have considered other systemic...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.